The month of April witnessed the FDA approving the first ever drug for tardive dyskinesia, a neurological disorder characterized by involuntary muscle movements. Want to know which drugs are awaiting FDA decision in May?
from RTT - Biotech http://ift.tt/2ps9NUT
via IFTTT
No comments:
Post a Comment